The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Systemic Antibiotic Prophylaxis After Gastrointestinal Hemorrhage in Cirrhotic Patients With A High Risk of Infection
Abstract
In cirrhotic patients with gastrointestinal hemorrhage, bacterial infections are frequent and play a significant role in mortality. We have previously found that patients with a Child–Pugh's class C or a rebleeding are a subgroup of cirrhotic patients with a high risk of infection. The aims of the study were (1) to validate these indicators and (2) to assess the effectiveness of a systemic antibiotic treatment in preventing bacterial infections in bleeding cirrhotics with a high risk of infection. One hundred and nineteen bleeding cirrhotic patients were divided into 3 groups. Patients with a Child–Pugh's class A–B and no rebleeding (i.e., with a low risk of infection) constituted group 1 (n = 55). Patients with a high risk of infection were randomly allocated to serve as controls (group 2, n = 34) or to receive the ciprofloxacin and a combination of amoxicillin and clavulanic acid for 3 days after hemorrhage (group 3, n = 30). This antibiotic prophylaxis was administered first intravenously and then orally when the bleeding was controlled. The study period was defined as 10 days after hemorrhage. Incidence of bacterial infections was significantly higher in patients from group 2 than in patients from group 1 (52.9% vs. 18.2%; P < .001). Moreover, infections were more severe in group 2: a sepsis syndrome or a septic shock developed in 66.7% of infected patients from this group, but in only 20% of infected patients from group 1. Incidence of bacterial infections was much lower in patients from group 3 than in those from group 2 (13.3% vs. 52.9%; P < .001). Eight patients from group 2 (23.5%) and 4 patients from group 3 (13.3%) died during the first four weeks (P–not significant). Septic shock was the cause of death in 3 patients from group 2 and in only 1 patient from group 3. The cost of antibiotic therapy, including antibiotic prophylaxis in group 3, was $208 ± $63 per patient in group 2 and $167 ± $42 per patient in group 3 ( P < .05). We conclude that (1) patients with a Child–Pugh's class C and/or a rebleeding are a subgroup of cirrhotic patients with a high risk of infection after gastrointestinal hemorrhage and that (2) in these patients, a prophylactic treatment with systemic antibiotics is very effective in preventing bacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ginés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Cited by
Garcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology · doi:10.1002/hep.28906 · Cited by 2,154
(2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.004 · Cited by 1,725
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., & Carey, W. (2007) · Hepatology · doi:10.1002/hep.21907 · Cited by 1,722
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Rimola, A., García-Tsao, G., Navasa, M., Piddock, L. J. V., Planas, R., Bernard, B., & Inadomi, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80201-9 · Cited by 1,064
Olmo, J. A. D., Peña, A., Serra, M. A., Wassel, A. H., Benages, A., & Rodrigo, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(01)68827-5 · Cited by 895
Improved survival after variceal bleeding in patients with cirrhosis over the past two decades
Carbonell, N., Pauwels, A., Serfaty, L., Fourdan, O., Lévy, V. G., & Poupon, R. (2004) · Hepatology · doi:10.1002/hep.20339 · Cited by 842
Self-citationBernard, B., Grangé, J.-D., Khac, E. N., Amiot, X., Opolon, P., & Poynard, T. (1999) · Hepatology · doi:10.1002/hep.510290608 · Cited by 836
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
Tripathi, D., Stanley, A. J., Hayes, P. C., Patch, D., Millson, C., Mehrzad, H., Austin, A., Ferguson, J. W., Olliff, S. P., Hudson, M., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309262 · Cited by 795
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., Carey, W. D., & the Practice Guidelines Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01481.x · Cited by 569
Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis
Tandon, P., & Garcia-Tsao, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-2008-1040319 · Cited by 551
Garcia–Tsao, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.22580 · Cited by 471
Fernández, J., del Arbol, L. R., Gómez, C., Durandez, R., Serradilla, R., Guarner, C., Planas, R., Arroyo, V., & Navasa, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.010 · Cited by 458
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study
Borzio, M., Salerno, F., Piantoni, L., Cazzaniga, M., Angeli, P., Bissoli, F., Boccia, S., Colloredo-Mels, G., Corigliano, P., Fornaciari, G., et al. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80134-1 · Cited by 438
Hou, M.-C., Lin, H.-C., Liu, T.-T., Kuo, B. I.-T., Lee, F.-Y., Chang, F.-Y., & Lee, S.-D. (2004) · Hepatology · doi:10.1002/hep.20126 · Cited by 429
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club
Wong, F., Bernardi, M., Balk, R., Christman, B., Moreau, R., Garcia-Tsao, G., Patch, D., Soriano, G., Hoefs, J., & Navasa, M. (2005) · Gut · doi:10.1136/gut.2004.038679 · Cited by 392
Management of bacterial infections in cirrhosis
Fernández, J., & Gustot, T. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60002-6 · Cited by 368
Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study
Bernard, B., Cadranel, J.-F., Valla, D., Escolano, S., Jarlier, V., & Opolon, P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90146-9 · Cited by 325
Chavez-Tapia, N. C., Barrientos-Gutierrez, T., Tellez-Avila, F., Soares-Weiser, K., Mendez-Sanchez, N., Gluud, C., & Uribe, M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04746.x · Cited by 304
Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding
Chavez-Tapia, N. C., Barrientos-Gutierrez, T., Tellez-Avila, F. I., Soares-Weiser, K., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002907.pub2 · Cited by 304
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective
Nadim, M. K., Durand, F., Kellum, J. A., Levitsky, J., O’Leary, J. G., Karvellas, C. J., Bajaj, J. S., Davenport, A., Jalan, R., Angeli, P., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.019 · Cited by 297
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
Jalan, R., & Williams, R. (2002) · Blood Purification · doi:10.1159/000047017 · Cited by 286
Bambha, K., Kim, W. R., Pedersen, R., Bida, J. P., Kremers, W. K., & Kamath, P. S. (2008) · Gut · doi:10.1136/gut.2007.137489 · Cited by 256
Metadata
- Authors
- Pauwels, A., Mostefa-Kara, N., Debenes, B., Degoutte, E., & Levy, V
- Venue
- Hepatology
- Published
- 1996-10
- Volume
- 24
- Issue
- 4
- Pages
- 802-806
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2045268670
- Cited by
- 197
- References
- 1
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.